EW Overview — StockExplainer

+228%

+12.6% per year

Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.

Country US

Exchange NYSE

Industry Medical - Devices

Sector Healthcare

Market Cap $43.37B

CEO Mr. Bernard J. Zovighian

Edwards Lifesciences Corporation is a company that makes medical devices to help people with heart problems. They create tools that allow doctors to replace or repair heart valves without needing to perform major surgery. Their products also help monitor patients' heart health, especially in hospitals. Founded in 1958 and based in California, Edwards Lifesciences focuses on improving patient care for those with serious heart conditions.

Streams of revenue

Transcatheter Heart Valves: 76%

Surgical Heart Valve Therapy: 18%

Transcatheter Mitral And Tricuspid Therapies: 7%

Geographic Distribution

UNITED STATES: 59%

Europe: 24%

Rest of World: 11%

JAPAN: 6%

Core Products

🔪

Surgical Heart Valves Surgical valve solutions

🩺

Critical Care Monitoring Patient monitoring tech

❤️

Transcatheter Heart Valves Heart valve replacement

Business Type

Business to Business

Competitive Advantages

🚚

Robust Distribution Network The combination of a direct sales force and independent distributors allows for effective product reach and strong customer relationships.

🛠️

Innovative Product Portfolio Edwards Lifesciences has a strong focus on innovation, with advanced products for heart valve replacement and repair that are minimally invasive, setting it apart from competitors.

📊

Strong Clinical Evidence and Reputation Edwards has built a solid reputation based on extensive clinical research and proven outcomes, fostering trust among healthcare providers and patients.

📈

Focus on Critical Care Monitoring Technology The company’s critical care solutions enhance patient monitoring and outcomes, tapping into the demand for advanced healthcare technologies.

🏆

Market Leadership in Transcatheter Solutions The company is a leader in transcatheter heart valve therapy, giving it a significant competitive edge in a growing market segment.

Key Business Risks

🩺

Clinical Risk Potential negative outcomes from surgical procedures using the company's products can lead to liability issues and reputational damage.

🏦

Market Competition Intense competition from other medical device companies can lead to pricing pressures and loss of market share.

⚖️

Regulatory Compliance Changes in healthcare regulations and compliance requirements may impact product approvals and market access.

🚧

Supply Chain Disruptions Disruptions in the supply chain can affect the availability of critical components, impacting production and delivery.

💻

Technological Obsolescence Rapid advancements in medical technology may render existing products obsolete, necessitating continuous innovation.

Meeting Expectations

7 /10

Higher values indicate better execution and credibility

Business Overview

Performance Analysis

Stock Price

Performance Analysis

Stock Price